Press release
Radiopharmaceutical Theranostics Market Insights Highlight Segment Expansion And Market Leadership
Radiopharmaceutical Theranostics Market
Projected Market Growth and Size of the Radiopharmaceutical Theranostics Market
The radiopharmaceutical theranostics market is anticipated to experience rapid growth, reaching a valuation of $6.64 billion by 2030. This corresponds to a compound annual growth rate (CAGR) of 15.3% during the forecast period. Factors propelling this expansion include increased funding in precision oncology, a rising preference for personalized radiopharmaceutical treatments, a surge in clinical trials exploring novel isotopes, enhanced partnerships linking diagnostic and therapeutic approaches, and continuous improvements in isotope supply chain technologies. Key trends shaping the future of this market involve the development of targeted theranostic radiopharmaceuticals, growing application of PET-based personalized therapies, wider acceptance of alpha and beta emitters for oncology purposes, expansion of cyclotron-based isotope production, and a stronger emphasis on precision oncology.
The radiopharmaceutical theranostics market size has grown rapidly in recent years. It will grow from $3.27 billion in 2025 to $3.76 billion in 2026 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to expansion of nuclear medicine applications, increasing cancer incidence rates, advancements in radioisotope production techniques, growth in diagnostic imaging integration, early adoption of theranostic treatment models.
Download a free sample of the radiopharmaceutical theranostics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11951&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Emerging Leading Companies in the Radiopharmaceutical Theranostics Industry
Several prominent players are active in the radiopharmaceutical theranostics arena, including Cardinal Health Inc., GE HealthCare Technologies Inc., Bayer AG, China Grand Pharmaceutical & Healthcare, Lantheus Medical Imaging Inc., Curium Pharma, Advanced Accelerator Applications, Telix Pharmaceuticals Ltd., Bracco Imaging S.p.A, NTP Radioisotopes SOC Ltd., Navidea Biopharmaceuticals Inc., Jubilant DraxImage Inc., NorthStar Medical Radioisotopes LLC, Blue Earth Diagnostics Ltd., Precirix NV, SpectronRx, Viewpoint Molecular Targeting Inc., NuView Life Sciences, Alpha-9 Theranostics Inc., RadioMedix Inc., RayzeBio Inc., Fusion Pharmaceuticals Inc., Actinium Pharmaceuticals Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Ariceum Therapeutics GmbH, Radiopharm Theranostics Ltd., Ratio Therapeutics Inc., Primo Biotechnology, and Bivision Biomedical Technology (Nanjing) Co. Ltd.
Strategic Moves by Radiopharm Theranostics to Advance Prostate Cancer Treatments
In March 2023, Radiopharm Theranostics, an Australian biotechnology firm specializing in radiopharmaceuticals, acquired Pharma15 Corporation for $4 million. This acquisition aims to advance next-generation radiopharmaceutical solutions targeting prostate cancer, striving to surpass existing PSMA-based therapies with innovative treatment options. Pharma15 Corporation, based in the United States, focuses on developing radio-immuno-theranostics platforms and related pharmaceutical products, enhancing Radiopharm's portfolio and research capabilities.
View the full radiopharmaceutical theranostics market report:
https://www.thebusinessresearchcompany.com/report/radiopharmaceutical-theranostics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Current Trends Highlighting the Future of Radiopharmaceutical Theranostics
Top companies in this space are heavily investing in theranostics aimed at cancer treatment, while also exploring applications for rare diseases. The goal is to deliver targeted therapies coupled with precise diagnostic tools for patients who have limited existing options. For example, in November 2023, GE HealthCare Technologies Inc., a leading US medical technology firm, introduced a suite of theranostic solutions specifically designed for cancer care. This innovative field of precision medicine combines therapeutic agents with advanced imaging technologies to accurately locate and destroy cancer cells.
Detailed Segmentation of the Radiopharmaceutical Theranostics Market
The radiopharmaceutical theranostics market is categorized into several segments:
1) Product Type: Alpha Emitters, Beta Emitters, Positron Emission Tomography (PET) Tracers
2) Source: Nuclear Reactors, Cyclotrons
3) Radioisotope: Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and other radioisotopes
4) Indication: Oncology, Cardiology, Neurology, and other medical indications
5) End User: Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and other end users
Subcategories include:
- Alpha Emitters: Actinium-225, Radium-223, Bismuth-213, and other alpha-emitting radiopharmaceuticals
- Beta Emitters: Iodine-131, Lutetium-177, Yttrium-90, and other beta-emitting radiopharmaceuticals
- Positron Emission Tomography (PET) Tracers: Fluorodeoxyglucose (FDG), Gallium-68, Carbon-11, and other PET tracers
This comprehensive segmentation offers a nuanced understanding of the various components driving the radiopharmaceutical theranostics market forward.
Key enhancements in our 2026 market reports include:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmaceutical Theranostics Market Insights Highlight Segment Expansion And Market Leadership here
News-ID: 4613849 • Views: …
More Releases from The Business Research Company
Renal Biomarkers Market Analysis Highlights Growth To $2.04 Billion By 2030 At 8 …
The renal biomarkers market is set to experience significant expansion over the coming years, driven by advancements in medical technologies and a growing emphasis on personalized healthcare. This sector is rapidly evolving as innovations and strategic collaborations push the boundaries of kidney disease diagnosis and treatment, offering promising opportunities for better patient outcomes.
Projected Growth Trajectory of the Renal Biomarkers Market
The renal biomarkers market is expected to expand substantially,…
Protein Stability Analysis Market Demonstrates Long-Term Growth Potential At 12. …
The field of protein stability analysis is rapidly evolving as biopharmaceutical research intensifies and the demand for precise, reliable data grows. This sector is poised for significant expansion driven by technological advancements and increasing regulatory requirements. Here's a detailed overview of the market's size, key players, emerging trends, and segmentation to better understand its current dynamics and future prospects.
Projected Expansion of the Protein Stability Analysis Market by 2030
The…
Remote Irritable Bowel Syndrome (IBS) Monitoring Market Study Highlights How Ind …
The remote irritable bowel syndrome (IBS) monitoring market is on the brink of significant expansion, driven by increasing healthcare digitization and personalized treatment approaches. As technology advances and patient-centered care gains prominence, this sector is set to transform how IBS is managed remotely, offering promising prospects for patients and healthcare providers alike.
Projected Market Size and Growth Trajectory for Remote IBS Monitoring
The remote IBS monitoring market is predicted to…
Protein Extracts From Single Cell Protein And Other Conventional Sources Market …
The market for protein extracts derived from single cell proteins and other traditional sources is poised for substantial growth in the coming years. As demand for sustainable and high-quality protein ingredients rises, this sector is attracting attention from investors and innovators alike. Let's explore the market size, leading players, emerging trends, and segment breakdowns shaping this evolving industry.
Market Size and Growth Outlook for Protein Extracts From Single Cell Protein and…
More Releases for Theranostics
Key Factor Supporting Global Theranostics Market Development in 2025: Rising Can …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Theranostics Market Size By 2025?
The overall scale of the theranostics sector has experienced swift expansion lately, charting an increase from a valuation of $111.1 billion in 2024 to an anticipated $122.98 billion by 2025, reflecting a compound annual growth rate (CAGR) of 10.7%; this…
Theranostics Market in 2025 Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Theranostics Market -(Product (Diagnostic imaging, Radiopharmaceuticals, Biomarker screening and Software), Application (Prostate Cancer, Bone Metastasis, Other Cancers, Other Application), End-user (Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Theranostics Market Size is valued…
Rising Cancer Prevalence Fuels Growth In The Theranostics Market Driver: Leading …
What combination of drivers is leading to accelerated growth in the theranostics market?
The theranostics market is forecasted to grow due to an upward trend in cancer cases. Cancer, a disease characterized by unchecked cell growth affecting numerous organs, is a leading cause of considerable illness and death globally. Theranostics, combining therapeutic and diagnostic aspects, holds significant prospects in managing cancer and chronic illnesses. This methodology paves the way for tailored…
Theranostics Market worth $4.3 billion by 2028
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall theranostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies.
Theranostics Market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3…
Theranostics Market: Pioneering Precision Medicine into 2030
The Theranostics Market was valued USD 1.9 Billion in 2023 and projected to reach USD 5.4 Billion by 2030, growing at a CAGR of 16.2% during the forecast period of 2024-2030.
The Theranostics Market report studies the competitive environment of the Theranostics Market based on company profiles and their efforts to increase product value and production. The Theranostics Market report discusses various factors driving or restraining the market, which will help…
Theranostics Market Is Booming Worldwide Just Published
Global Theranostics Market: An Overview
Theranostics is a new field of medicine which relies on targeted therapies to conduct specific targeted tests. These tests are mainly used for various forms of cancers. The key concern in the therapeutics involve patient centric care with the help of more personalised and precise approach. The technique relies on the use of diagnostic and therapeutic applications to form a single agent. The system is known…
